SS
LXRX icon

SBI Securities’s Lexicon Pharmaceuticals LXRX Stock Holding History

SBI Securities’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1K Buy
19,205
+15,124
+371% +$29.5K ﹤0.01% 1194
2026
Q1 		$6.37K Buy
4,081
+1,063
+35% +$1.55K ﹤0.01% 1927
2025
Q4 		$3.47K Sell
3,018
-12,029
-80% -$16.5K ﹤0.01% 2174
2025
Q3 		$20.3K Sell
15,047
-4,190
-22% -$4.75K ﹤0.01% 1445
2025
Q2 		$18.2K Buy
19,237
+15,917
+479% +$10.3K ﹤0.01% 1449
2025
Q1 		$1.53K Buy
3,320
+256
+8% +$162 ﹤0.01% 2411
2024
Q4 		$2.26K Buy
+3,064
New +$3.69K ﹤0.01% 2260

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SBI Securities's LXRX Position: Q2 2026 in Review

SBI Securities increased its Lexicon Pharmaceuticals (LXRX) stake by 371% in Q2 2026, buying an estimated $29.5K and bringing the position to 19,205 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1194.

SBI Securities first reported a position in LXRX in Q4 2024 and has held it in 7 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • SBI Securities held 19,205 shares of Lexicon Pharmaceuticals worth $46.1K as of Q2 2026.
  • SBI Securities bought 15,124 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $29.5K.
  • Lexicon Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1194 holding.
  • SBI Securities first reported a position in Lexicon Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.